Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:1.16.3.1 (ceruloplasmin)
 5,074 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Two experiments were conducted to compare the effects of a progesterone-estradiol implant (PEI) with no implant (NI) and 20 g of copper oxide needles (CuON) with no CuON on grazing, subsequent feedlot performance, and selected serum constituents of steers. In Exp. 1, 114 Limousin crossbred yearling steers (317 kg average initial BW) were stocked continuously on Acremonium coenophialum-infected tall fescue (Festuca arundinacea Schreb.)-ladino clover (Trifolium repens L.) pastures (C) or were rotated to bermuda grass (Cynodon dactylon [L.] Pers.) during summer months (R) of two consecutive years. Implant and copper treatments were applied within pasture. Blood samples were collected four times during each grazing season. Continuously stocked steers had greater (P less than .05) grazing gain, less (P less than .10) feedlot gain, and heavier (P less than .05) carcass weights than R steers did. Implanted steers had greater (P less than .05) pasture but lesser (P less than .05) feedlot gains than did NI steers. Prolactin concentrations were greater (P less than .05) from R than from C steers in late summer 1988. Ceruloplasmin was greater (P less than .01) with CuON than without on the last three and last two sampling dates in 1988 and 1989, respectively. In Exp. 2, blood samples were collected twice from 40 mixed-breed steers (283 kg average initial BW) receiving the same implant and copper treatments as in Exp. 1 and grazing infected fescue for one season. Serum ceruloplasmin and copper concentrations were increased (P less than .01) by CuON, but other measurements did not differ among treatments. Summer grazing of bermuda grass increased serum copper, ceruloplasmin, and prolactin but decreased grazing performance. Implanting increased grazing performance. Copper oxide needles increased serum ceruloplasmin and copper concentrations but did not affect steer performance.
 ...
PMID:Implant and copper oxide needles for steers grazing Acremonium coenophialum-infected tall fescue pastures: effects on grazing and subsequent feedlot performance and serum constituents. 142 96

Certain metabolic effects were investigated in post-menopausal women undergoing oral estrogen replacement therapy for 6 months using various substances. The increases in serum concentration of the estrogen-sensitive proteins, pregnancy zone protein (PZP), and sex hormone binding globulin (SHBG) had very similar and dose-dependent patterns. Ethinyl-estradiol was found to be much more potent than the "natural" estrogens. Estriol in various doses did not increase the protein level. Gonadotropin inhibition occurred in a dose-dependent manner. In terms of FSH suppression ethinyl-estradiol was approximately 120 times as potent as the "natural" estrogens. There was a striking resemblance between the "estrogenicity" of four different estrogens when expressed both in inhibition of gonadotropins and in induction of the two serum proteins SHBG and ceruloplasmin. Estriol caused a significant depression of FSH when given orally in a dose of 2 mg three times daily. Prolactin was found to decrease during treatment with low doses of estrogens. Estrogen therapy was found to have only moderate effects on adrenal androgens. Tamoxifen, and anti-estrogen, was found to exert distinctly estrogenic effects during treatment of post-menopausal women. In post-menopausal women with low amounts of circulating estrogens the tamoxifen-receptor complex itself may produce a net estrogenic response. Serum samples from post-menopausal women treated with ethinyl estradiol 0.05 mg and estrone sulphate 2.5 mg daily were found to reduce the lymphocyte reactivity in mixed lymphocyte cultures.
 ...
PMID:Estrogen replacement therapy after the menopause. Estrogenicity and metabolic effects. 628 33